title: Development of biologically active compounds by combining 3D QSAR and structure-based design methods.
abstract: One of the major challenges in computational approaches to drug design is the accurate prediction of the binding affinity of novel biomolecules. In the present study an automated procedure which combines docking and 3D-QSAR methods was applied to several drug targets. The developed receptor-based 3D-QSAR methodology was tested on several sets of ligands for which the three-dimensional structure of the target protein has been solved--namely estrogen receptor, acetylcholine esterase and protein-tyrosine-phosphatase 1B. The molecular alignments of the studied ligands were determined using the docking program AutoDock and were compared with the X-ray structures of the corresponding protein-ligand complexes. The automatically generated protein-based ligand alignment obtained was subsequently taken as basis for a comparative field analysis applying the GRID/GOLPE approach. Using GRID interaction fields and applying variable selection procedures, highly predictive models were obtained. It is expected that concepts from receptor-based 3D QSAR will be valuable tools for the analysis of high-throughput screening as well as virtual screening data.
authors.affiliation: Institute for Pharmaceutical Chemistry, Heinrich-Heine-Universität Düsseldorf, D-40225 Düsseldorf, Germany. sippl@pharm.uni-duesseldorf.de
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Sippl
mesh_terms: D001665:Binding Sites; D002800:Cholinesterase Inhibitors / Q000737:chemistry / Q000494:pharmacology; D003198:Computer Simulation; D017076:Computer-Aided Design; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology; D008024:Ligands; D008958:Models, Molecular; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1; D017027:Protein Tyrosine Phosphatases / Q000037:antagonists & inhibitors; D021281:Quantitative Structure-Activity Relationship; D011960:Receptors, Estrogen / Q000819:agonists
chemical_list: D002800:Cholinesterase Inhibitors; D004791:Enzyme Inhibitors; D008024:Ligands; D011960:Receptors, Estrogen; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1; D017027:Protein Tyrosine Phosphatases